Cargando…
P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
Autores principales: | Pfeiffer, C., Beer, P., Asnagli, H., Bolomsky, A., Grandits, A., Schneller, A., Huber, J., Zojer, N., Schreder, M., Parker, A., Ludwig, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428997/ http://dx.doi.org/10.1097/01.HS9.0000846336.64675.44 |
Ejemplares similares
-
P873: CARFILZOMIB RESISTANCE IS ASSOCIATED WITH SIGNIFICANT DEREGULATION OF THE BH3 FAMILY PROTEINS
por: Schneller, A., et al.
Publicado: (2022) -
Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation
por: Minet, Norbert, et al.
Publicado: (2023) -
P1308: SELECTIVE SMALL MOLECULE INHIBITION OF CTP SYNTHASE 1 (CTPS1) SUPPRESSES T CELL PROLIFERATION AND CYTOKINE RELEASE, HIGHLIGHTING A NOVEL THERAPEUTIC TARGET FOR GRAFT-VERSUS-HOST DISEASE
por: Beer, P., et al.
Publicado: (2022) -
Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
por: Schneller, Anja, et al.
Publicado: (2021) -
Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells
por: Sun, Zhe, et al.
Publicado: (2022)